Tourmaline Bio Inc (TRML)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Tourmaline Bio Inc Stock (TRML) Company Profile

Tourmaline Bio Inc

646-481-9832

27 WEST 24TH STREET, NEW YORK

Prossima data di guadagno

Ultimi documenti SEC

TRML's Discussions on Twitter

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-15	Iniziato	Jefferies	Buy
2023-12-04	Ripresa	H.C. Wainwright	Buy
2023-11-17	Iniziato	Truist	Buy
2023-10-31	Iniziato	Guggenheim	Buy
2023-10-25	Iniziato	Piper Sandler	Overweight
2022-10-20	Iniziato	H.C. Wainwright	Buy
2022-07-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight

Mostra tutto

Tourmaline Bio Inc Borsa (TRML) Ultime notizie

Tourmaline Bio Inc Azioni (TRML) Dati Finanziari

Tourmaline Bio Inc Azioni (TRML) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Kulkarni Sandeep Chidambar	CEO	Aug 16 '24	Buy	13.79	5,221	71,998	5,221
MCDADE MARK	Director	Jan 29 '24	Buy	32.50	100,000	3,250,000	448,431
Kulkarni Sandeep Chidambar	CEO	Nov 17 '23	Buy	16.99	4,000	67,960	729,735
Thiara Parvinder	Director	Nov 17 '23	Buy	17.31	1,000	17,310	83,782
Castelein Caley	Director	Oct 27 '23	Buy	14.55	15,800	229,890	516,519
Castelein Caley	Director	Oct 25 '23	Buy	12.07	4,200	50,694	500,719
Kulkarni Sandeep Chidambar	CEO	Oct 26 '23	Buy	12.25	5,000	61,250	725,735
Kulkarni Sandeep Chidambar	CEO	Oct 24 '23	Buy	10.68	4,650	49,662	720,735
KANTOFF AARON	Director	Oct 24 '23	Buy	11.86	7,500	88,950	45,391
Thiara Parvinder	Director	Oct 24 '23	Buy	10.66	5,000	53,300	80,782

Tourmaline Bio Inc (TRML)

Tourmaline Bio Inc Stock (TRML) Company Profile

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

Tourmaline Bio Inc Borsa (TRML) Ultime notizie

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $61.80 Average PT from Brokerages - MarketBeat

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Recommendation of “Buy” from Analysts - Defense World

Tourmaline Bio amends bylaws, updates proxy rules - Investing.com

The Attractiveness of Investing In Tourmaline Bio Inc (TRML) is Growing - Knox Daily

Tourmaline Bio amends bylaws, updates proxy rules - Investing.com India

Tourmaline Bio Showcases Promising Candidate in Updated Presentation - TipRanks

Tourmaline Oil Corp. (TSE:TOU) Senior Officer Mike Rose Purchases 2,500 Shares of Stock - Defense World

Tourmaline Bio to Present at Upcoming Investor Conferences - StockTitan

Investing in Tourmaline Bio Inc (TRML) Is Getting More Attractive - Knox Daily

A Tale of Resilience: Tourmaline Bio Inc Amid Stock Market Turbulence - The InvestChronicle

Tourmaline Bio CEO buys $26.4k of company stock - Investing.com India

Tourmaline Bio CEO buys $26.4k of company stock - Investing.com

Tourmaline Bio CEO buys $26.4k of company stock By Investing.com - Investing.com UK

Tourmaline Bio (NASDAQ:TRML) versus Turnstone Biologics (NASDAQ:TSBX) Head-To-Head Review - Defense World

Tourmaline Bio, Inc. (NASDAQ:TRML) CEO Sandeep Chidambar Kulkarni Purchases 5,221 Shares of Stock - Defense World

INFINI RES FPO [I88] (ASX:I88) Insider Charles Armstrong Acquires 150,000 Shares of Stock - Defense World

SG Americas Securities LLC Purchases Shares of 33,666 Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

4,526 Shares in Innovator Growth-100 Power Buffer ETF – July (BATS:NJUL) Bought by Brookstone Capital Management - Defense World

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $61.80 Consensus Target Price from Brokerages - MarketBeat

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Judges Scientific (LON:JDG) PT Raised to £124 at Berenberg Bank - Defense World

Tourmaline Bio CEO buys $71,997 in company stock - Investing.com India

Tourmaline Bio, Inc. (NASDAQ:TRML) CEO Sandeep Chidambar Kulkarni Purchases 5,221 Shares - MarketBeat

Tourmaline Bio CEO buys $71,997 in company stock - Investing.com

Tourmaline Bio CEO buys $71,997 in company stock By Investing.com - Investing.com UK

California State Teachers Retirement System Invests $334,000 in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Q3 2024 EPS Estimates for Tourmaline Bio, Inc. (NASDAQ:TRML) Reduced by Analyst - MarketBeat

HC Wainwright Analysts Reduce Earnings Estimates for Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Tourmaline Bio's (TRML) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Tourmaline Bio (NASDAQ:TRML) Receives Buy Rating from HC Wainwright - Defense World

Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Acquired by Vanguard Group Inc. - MarketBeat

Vanguard Group Inc. Has $20.94 Million Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Tourmaline Bio (NASDAQ:TRML) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Tourmaline Bio (NASDAQ:TRML) Issues Quarterly Earnings Results - Defense World

Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock - Yahoo Finance

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Yahoo Finance

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - ForexTV.com

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - The Bakersfield Californian

Janus Henderson Group PLC Invests $266,000 in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Concurrent Technologies (LON:CNC) Shares Pass Above Two Hundred Day Moving Average of $97.15 - Defense World

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - StockTitan

Tourmaline Bio publishes design of Phase II clinical trial for TOUR006 - Yahoo Finance

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024 - Yahoo Finance

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024 - ForexTV.com

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024 - StockTitan

BNP Paribas Financial Markets Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Tourmaline Bio, Inc. (NASDAQ:TRML) Sees Significant Increase in Short Interest - MarketBeat

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Swiss National Bank Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Swiss National Bank Purchases Shares of 32,000 Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

A Guide To The Risks Of Investing In Tourmaline Bio Inc (TRML) - Knox Daily

Tourmaline Bio Inc Azioni (TRML) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Tourmaline Bio Inc Azioni (TRML) insider trading

Simile a TRML